EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Multizentrische StudieRandomisierte kontrollierte StudieOpen Access

Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction

A W J Van't Hof, C M Gibson, S A O F Rikken, J L Januzzi, C B Granger, A van Beurden, S Rasoul, L Ruiters, J Vainer, A Verburg, F Arslan, J W Jukema und 34 weitere

NEJM Evidence · 23.12.2025 · 5 (1)

DOI: 10.1056/evidoa2500268 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift NEJM Evidence, erschienen am 23.12.2025. Verfasst von A W J Van't Hof und 45 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Medical Center Maastricht, Maastricht, the Netherlands. Hauptthemen laut MEDLINE: Platelet Aggregation Inhibitors, Platelet Glycoprotein GPIIb-IIIa Complex, ST Elevation Myocardial Infarction. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet Aggregation InhibitorsPlatelet Glycoprotein GPIIb-IIIa ComplexST Elevation Myocardial InfarctionAgedFemaleHumansMaleMiddle AgedDouble-Blind MethodHemorrhageInjections, SubcutaneousTreatment Outcome

Substanzen

Platelet Aggregation InhibitorsPlatelet Glycoprotein GPIIb-IIIa Complex

Autor:innen und Institutionen

  • Department of Cardiology, University Medical Center Maastricht, Maastricht, the Netherlands.
  • Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands.
  • Department of Cardiology, Zuyderland Medical Center, Heerlen, the Netherlands.
  • Boston Clinical Research Institute, Boston, MA, USA.
  • Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands.
  • Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Van't Hof, A. W. J., Gibson, C. M., Rikken, S. A. O. F., Januzzi, J. L., Granger, C. B., van Beurden, A., Rasoul, S., Ruiters, L., Vainer, J., Verburg, A., Arslan, F., Jukema, J. W., Durieux, M., Polad, J., van Vliet, R., van den Branden, B. J. L., Magro, M., Remkes, W., Beelen, J., …, & Montalescot, G. (2025). Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction. NEJM Evidence, 5(1). https://doi.org/10.1056/evidoa2500268

Vancouver

Van't Hof AWJ, Gibson CM, Rikken SAOF, Januzzi JL, Granger CB, van Beurden A, et al. Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction. NEJM Evidence. 2025;5(1). doi:10.1056/evidoa2500268

BibTeX
@article{VantHof2025,
  author = {Van't Hof, A W J and Gibson, C M and Rikken, S A O F and Januzzi, J L and Granger, C B and van Beurden, A and Rasoul, S and Ruiters, L and Vainer, J and Verburg, A and Arslan, F and Jukema, J W and Durieux, M and Polad, J and van Vliet, R and van den Branden, B J L and Magro, M and Remkes, W and Beelen, J and Hermanides, R and Tolsma, R and Gosselink, M and Vinereanu, D and Chioncel, V and van de Hoef, T P and Boomars, R and Arkenbout, K E and van Houwelingen, G K and Hengstman, G and van de Wetering, H and Pisters, R and Kala, P and Merkely, B and Ecollan, P and Lapostolle, F and Giugliano, R P and Welsh, R C and Levy, M and Arias-Mendoza, A and Baron, N and Cociorva, D and Wittes, J and Unger, E F and Coller, B S and Ten Berg, J M and Montalescot, G},
  title = {Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction},
  journal = {NEJM Evidence},
  year = {2025},
  volume = {5},
  number = {1},
  doi = {10.1056/evidoa2500268}
}
Kostenlos starten →